Sirio Nutrition (California) LLC
City of Industry, CA, United States
Due-diligence reportFind an accredited testing lab and confirm its scope covers your product and methods.
Sirio Nutrition (California) LLC is a dietary supplement manufacturer in City of Industry, CA, United States, certified to NSF/ANSI 455-2 GMP, with 3 manufacturing facilities on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. It is also a USDA Organic certified operation. Listed dosage forms: capsules, gummies, powders, softgels and tablets.
- Website
- bestformulations.com
- Phone
- 626-912-9998
- Facilities listed
- 3
- Last checked
Dosage forms
As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.
Certified facilities
Manufacturing (3)
17758 Rowland Street, City of Industry, CA 91748, United States
- Coating
- Encapsulation
- Mixing
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Bulk Packaging
- Packaging/Labeling Operation - Primary Packaging
- Tablet Compression
- Warehousing
938 Radecki Court, City of Industry, CA 91748, United States
- Encapsulation
- Mixing
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Bulk Packaging
- Quality Unit Operations
- Warehousing
17775 Rowland Street, City of Industry, CA 91748, United States
- Mixing
- Molding
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Bulk Packaging
- Packaging/Labeling Operation - Primary Packaging
- Warehousing
How Sirio Nutrition (California) LLC compares
Among the 769 manufacturers we list, as of our last check.
- One of 22 gummy manufacturers we list in California, and 116 in the United States. All gummy manufacturers in the USA · All in California
- One of 64 capsule manufacturers we list in California, and 325 in the United States. All capsule manufacturers in the USA · All in California
- One of 48 tablet manufacturers we list in California, and 228 in the United States. All tablet manufacturers in the USA · All in California
- NSF lists molding at one of its facilities, an operation listed for 121 of the 769 manufacturers we list.
- On 2 of the registries we check: NSF/ANSI 455-2 and USDA Organic. 165 of the 769 manufacturers we list are on 2 or more.
FDA recall records
No food or dietary supplement recall found under the name Sirio Nutrition (California) LLC in FDA’s enforcement reports, as of .
We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check
FDA inspections
FDA lists 8 food or dietary supplement inspections at facilities matching Sirio Nutrition (California) LLC, from 2010 to 2025, as of . 1 found no objectionable conditions, 6 found conditions the firm was left to correct, and 1 led FDA to recommend official action.
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
City Of Industry, California
3 citations posted:
- Specifications - components (21 CFR 111.70(b))
- Specifications - finished dietary supplement (21 CFR 111.70(e))
- Quality control production, process control; material review, disposition (21 CFR 111.113(a)(1))
Full citation text
Specifications - components (21 CFR 111.70(b))
For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications and necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met.
Specifications - finished dietary supplement (21 CFR 111.70(e))
You did not establish product specifications for identity, purity and strength.
Quality control production, process control; material review, disposition (21 CFR 111.113(a)(1))
Your quality control personnel did not conduct a material review and make a disposition decision for a specification established for the production and process control system that was not met.
FEI 3003121131
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
City Of Industry, California
5 citations posted:
- Specifications - component identity (21 CFR 111.70(b)(1))
- Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
- Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))
- Specifications met limits on contamination ; basis (21 CFR 111.75(c)(3))
See all 5 citations
Specifications - component identity (21 CFR 111.70(b)(1))
You did not establish an identity specification for each component.
Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
You did not establish product specifications for the purity, strength and composition of the finished dietary supplement.
Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))
You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.
Specifications met limits on contamination ; basis (21 CFR 111.75(c)(3))
You did not provide adequate documentation of your basis for determining that compliance with the specification you selected for the limits on contamination that may adulterate or that may lead to adulteration of the dietary supplement will ensure that the finished batch of dietary supplement will not be adulterated as a result of such contamination.
Quality control - batch, product specifications (21 CFR 111.123(b)(2))
Your quality control personnel approved and released for distribution a batch of dietary supplement that did not meet established product specifications.
FEI 3003121131
No action indicated · No objectionable conditions found
Inspected
City Of Industry, California
FEI 3003121131
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
City Of Industry, California
1 citation posted:
- Written procedures - tests, examinations; specifications met (21 CFR 111.303)
Full citation text
Written procedures - tests, examinations; specifications met (21 CFR 111.303)
You did not follow written procedures for the tests and examinations conducted to determine whether specifications are met.
FEI 3003121131
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
City Of Industry, California
3 citations posted:
- Specifications met - identity, purity, strength, composition (21 CFR 111.73)
- Written procedures - quality control operations (21 CFR 111.103)
- Quality control - processes, specifications, written procedures (21 CFR 111.105(a))
Full citation text
Specifications met - identity, purity, strength, composition (21 CFR 111.73)
You did not determine whether you met established product specifications for strength and composition of the finished batch of the dietary supplement.
Written procedures - quality control operations (21 CFR 111.103)
You did not follow written procedures for quality control operations.
Quality control - processes, specifications, written procedures (21 CFR 111.105(a))
Your quality control personnel did not approve or reject specifications that may affect the identity, purity, strength, or composition of a dietary supplement.
FEI 3003121131
Show all 8 inspections
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
City Of Industry, California
3 citations posted:
- Specifications - components (21 CFR 111.70(b))
- Specifications - finished dietary supplement (21 CFR 111.70(e))
- Quality control production, process control; material review, disposition (21 CFR 111.113(a)(1))
Full citation text
Specifications - components (21 CFR 111.70(b))
For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications and necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met.
Specifications - finished dietary supplement (21 CFR 111.70(e))
You did not establish product specifications for identity, purity and strength.
Quality control production, process control; material review, disposition (21 CFR 111.113(a)(1))
Your quality control personnel did not conduct a material review and make a disposition decision for a specification established for the production and process control system that was not met.
FEI 3003121131
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
City Of Industry, California
5 citations posted:
- Specifications - component identity (21 CFR 111.70(b)(1))
- Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
- Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))
- Specifications met limits on contamination ; basis (21 CFR 111.75(c)(3))
See all 5 citations
Specifications - component identity (21 CFR 111.70(b)(1))
You did not establish an identity specification for each component.
Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
You did not establish product specifications for the purity, strength and composition of the finished dietary supplement.
Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))
You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.
Specifications met limits on contamination ; basis (21 CFR 111.75(c)(3))
You did not provide adequate documentation of your basis for determining that compliance with the specification you selected for the limits on contamination that may adulterate or that may lead to adulteration of the dietary supplement will ensure that the finished batch of dietary supplement will not be adulterated as a result of such contamination.
Quality control - batch, product specifications (21 CFR 111.123(b)(2))
Your quality control personnel approved and released for distribution a batch of dietary supplement that did not meet established product specifications.
FEI 3003121131
No action indicated · No objectionable conditions found
Inspected
City Of Industry, California
FEI 3003121131
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
City Of Industry, California
1 citation posted:
- Written procedures - tests, examinations; specifications met (21 CFR 111.303)
Full citation text
Written procedures - tests, examinations; specifications met (21 CFR 111.303)
You did not follow written procedures for the tests and examinations conducted to determine whether specifications are met.
FEI 3003121131
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
City Of Industry, California
3 citations posted:
- Specifications met - identity, purity, strength, composition (21 CFR 111.73)
- Written procedures - quality control operations (21 CFR 111.103)
- Quality control - processes, specifications, written procedures (21 CFR 111.105(a))
Full citation text
Specifications met - identity, purity, strength, composition (21 CFR 111.73)
You did not determine whether you met established product specifications for strength and composition of the finished batch of the dietary supplement.
Written procedures - quality control operations (21 CFR 111.103)
You did not follow written procedures for quality control operations.
Quality control - processes, specifications, written procedures (21 CFR 111.105(a))
Your quality control personnel did not approve or reject specifications that may affect the identity, purity, strength, or composition of a dietary supplement.
FEI 3003121131
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
City Of Industry, California
FEI 3003121131
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
City Of Industry, California
6 citations posted:
- Specifications met in-process purity, strength, composition (21 CFR 111.73)
- Specifications met - identity, purity, strength, composition (21 CFR 111.73)
- Quality control - reject; specification not met (21 CFR 111.113(b)(2))
- Batch record - date, time; maintenance (21 CFR 111.260(b))
See all 6 citations
Specifications met in-process purity, strength, composition (21 CFR 111.73)
You did not determine whether you met in-process specifications to ensure the strength and composition of the dietary supplements.
Specifications met - identity, purity, strength, composition (21 CFR 111.73)
You did not determine whether you met established product specifications for strength and composition of the finished batch of the dietary supplement.
Quality control - reject; specification not met (21 CFR 111.113(b)(2))
Your quality control personnel did not reject a dietary supplement when an established specification was not met.
Batch record - date, time; maintenance (21 CFR 111.260(b))
Your batch production records did not include the identity of equipment and processing lines used in producing the batch.
Batch record - manufacture (21 CFR 111.260(j))
Your batch production records did not include documentation, at the time of performance, of the manufacture of the batch.
SOPs not followed / documented (21 CFR 211.100(b))
Written production and process control procedures are not documented at the time of performance.
FEI 3003121131
Official action indicated · Regulatory or administrative action recommended
Inspected
City Of Industry, California
14 citations posted:
- Physical plant - separate areas - holding (21 CFR 111.20(c)(7))
- Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
- Specifications met - identity, purity, strength, composition (21 CFR 111.73)
- Quality control master manufacturing record; material review, disposition (21 CFR 111.113(a)(2))
See all 14 citations
Physical plant - separate areas - holding (21 CFR 111.20(c)(7))
You did not use separate or defined areas of adequate size or other control systems prevent contamination or mixups of components or dietary supplements during holding operations.
Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
You did not establish written procedures for maintaining, cleaning, and sanitizing, equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements.
Specifications met - identity, purity, strength, composition (21 CFR 111.73)
You did not determine whether you met established product specifications for strength and composition of the finished batch of the dietary supplement.
Quality control master manufacturing record; material review, disposition (21 CFR 111.113(a)(2))
Your quality control personnel did not conduct a material review and make a disposition decision when a batch deviated from the master manufacturing record.
Quality control - reject; specification not met (21 CFR 111.113(b)(2))
Your quality control personnel did not reject a dietary supplement when an established specification was not met.
Master manufacturing record - specifications; quality (21 CFR 111.205(b)(1))
Your master manufacturing record did not identify specifications for the points, steps, or stages in the manufacturing process where control is necessary to ensure the quality of the dietary supplement.
Adequate lab facilities not available (21 CFR 211.22(b))
Adequate lab facilities for testing and approval or rejection of components and drug products are not available to the quality control unit.
Defined areas of adequate size for operations (21 CFR 211.42(c))
The separate or defined areas and control systems necessary to prevent contamination or mix-ups are deficient.
Written procedures not established/followed (21 CFR 211.67(b))
Written procedures are not established for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.
Absence of Written Procedures (21 CFR 211.100(a))
There are no written procedures for production and process controls designed to assure that the drug products have the identity, strength, quality, and purity they purport or are represented to possess.
Approval and review of procedures (21 CFR 211.100(a))
Written procedures are not drafted, reviewed and approved by the appropriate organizational units and reviewed and approved by the quality control unit.
Sampling and testing plans not described (21 CFR 211.165(c))
Sampling and testing plans for drug products are not described in written procedures which include the method of sampling and number of units per batch to be tested.
Test methods (21 CFR 211.165(e))
The accuracy, sensitivity, specificity, and reproducibility of test methods have not been established.
Review of representative number of batches (21 CFR 211.180(e)(1))
Written procedures are not followed for evaluations conducted at least annually to review records associated with a representative number of batches, whether approved or rejected.
FEI 3003121131
We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check
What we checked, and what we didn’t
Confirmed from public registry listings
Last checked
- NSF/ANSI 455-2 GMP certification
- USDA Organic certified operation
- 3 facility addresses
- Dosage forms in the certified scope
- Operations listed for each facility
Not verified by us
- Minimum order quantity (MOQ): the smallest order they accept
- Lead times and current capacity
- Prices
- Other certifications, like kosher, halal or NSF Certified for Sport
- Whether they’re taking new clients
- Conditions inside the facility. We don’t visit or audit facilities.
Ask about these in your quote request. How we verify
Other gummy manufacturers in the United States
NSF lists 4 gummy facilities, including one in Tempe, AZ
Tempe, AZ, United States21stcenturyvitamins.com
- Capsules
- Gummies
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Tablet compression
- Encapsulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a gummy facility in Garden Grove, CA
Garden Grove, CA, United Statespackaging.com
- Capsules
- Gummies
- Powders
- Softgels
- Tablets
NSF/ANSI 455-2checked Nov 19, 2026NSF lists 2 gummy facilities, including one in St. Augustine, FL
St. Augustine, FL, United Statesactivegummy.com
- Gummies
Operations:- Molding
- Coating
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a gummy facility in Merrilville, IN
Merrilville, IN, United Statesalbanesecandy.com
- Gummies
Operations:- Molding
- Liquid formulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a gummy facility in Miami, FL
Miami, FL, United Statesalfavitamins.com
- Capsules
- Gummies
- Liquids
- Softgels
- Tablets
Operations:- Pasteurization
- Coating
- Liquid formulation
- Tablet compression
- +1 more
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a gummy facility in Dallas, TX
Dallas, TX, United Statesforeverliving.com
- Gummies
- Liquids
- Powders
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Liquid formulation
- Tablet compression
- +1 more
NSF/ANSI 455-2checked Nov 19, 2026